← Back to all earnings calls

Avalo Therapeutics, Inc. Q2 FY2022 Earnings Call

Avalo Therapeutics, Inc. (AVTX)

Earnings Call FY2022 Q2 Call date: 2022-08-04 Concluded

Share

Quarter scorecard

Revenue

$1.03M

-69.2% YoY

Diluted EPS

$-331.20

Net income

$

Documents & deck